Country: Ирска
Језик: Енглески
Извор: HPRA (Health Products Regulatory Authority)
Glucose anhydrous
Fresenius Kabi Limited
B05BA; B05BA03
Glucose anhydrous
5 percent weight/volume
Solution for infusion
Product subject to prescription which may not be renewed (A)
Solutions for parenteral nutrition; carbohydrates
Not marketed
2004-01-09
2 Pregnancy and breast-feeding GLUCOSE 5 % can be used during pregnancy or breast-feeding. However, you should tell your doctor if you are pregnant, if you think you are pregnant or if you are breast-feeding. 3. HOW YOU ARE GIVEN GLUCOSE 5 %? You will receive your medicine by slow intravenous infusion ('IV drip'). The rate at which the infusion is given and the volume infused will depend on your own specific requirements. Your doctor will decide on the correct dose for you to receive. 4. POSSIBLE SIDE EFFECTS Like all medicines, GLUCOSE 5 % can cause side effects, although not everybody gets them. The following undesirable effects may occur very rarely : • hyperglycaemia (too much sugar in the blood), • polyuria (frequent emission of urine) If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. 5. HOW TO STORE GLUCOSE 5 %? Keep out of the reach and sight of children. Do not use GLUCOSE 5 % after the expiry date which is stated on the label after EXP. Do not store above 25 °C. Your doctor or nurse will ensure the solution is clear and free from particles before use. Any solution remaining after treatment should be discarded. 6. FURTHER INFORMATION What GLUCOSE 5 % contains? • The active substance is: Glucose anhydrous...................................................50 g/l As glucose monohydrate .........................................55 g/l Osmolality:................................................300 mosmol/kg Osmolarity: ..................................................278 mosmol/l Carbohydrate caloric content: 200 kcal/l pH = 3.5 – 6.5 • The other ingredients are: hydrochloride acid (concentrated), sodium hydroxide, water for injections. 1 Read all of this leaflet carefully before you start using this medicine. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • If any of the side effects gets serious, or if you notice any side effects Прочитајте комплетан документ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Glucose 5% w/v Solution for Infusion. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Glucose anhydrous........................................................................... 50 g/l As glucose monohydrate................................................................... 55 g/l Each ml contains 50 mg anhydrous glucose. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for infusion. Clear solution, non coloured to slightly yellow. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS This medicine is indicated in the following situations: Rehydration when there is loss of water greater than loss of sodium chloride and other osmoles. Prevention of dehydration. Vehicle for other medicines during the preoperative, peroperative and immediate postoperative periods. Prevention and treatment of ketosis during malnutrition. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Intravenous infusion by peripheral or central vein. Posology is to be adapted according to patient's clinical status, body weight, diet and any possible other treatments. Infusion rate must not exceed a volume corresponding to 0.5 g of glucose per minute. 4.3 CONTRAINDICATIONS Administration of this medicine is contraindicated in the following cases: Water overload. Glucose intolerance. Osmolality: 300 mosmol/kg Osmolarity: 278 mosmol/l Carbohydrate caloric content: 200 kcal/l pH = 3.5 - 6.5 H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ Прочитајте комплетан документ